FMP
BioMarin Pharmaceutical’s Vosoritide Gets FDA Accelerated Approval
Nov 23, 2021 1:15 AM - Davit Kirakosyan
Image credit: FMP
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) made an announcement, according to which the FDA has granted accelerated approval for vosoritide in children age 5 or older with achondroplasia and active growth plates.
The company plans to fully launch Voxogo in the US in December with net pricing of around $240,000 per patient per year, slightly below the company's initial launch pricing in the EU. Management spoke positively toward their pre-launch activities noting expectations for Voxogo to represent the company's largest launch and potentially highest grossing product to date.
Other Blogs
Sep 11, 2023 1:38 PM - Rajnish Katharotiya
P/E Ratios Using Normalized Earnings
Price to Earnings is one of the key metrics use to value companies using multiples. The P/E ratio and other multiples are relative valuation metrics and they cannot be looked at in isolation. One of the problems with the P/E metric is the fact that if we are in the peak of a business cycle, earni...
Sep 11, 2023 1:49 PM - Rajnish Katharotiya
What is Price To Earnings Ratio and How to Calculate it using Python
Price-to-Earnings ratio is a relative valuation tool. It is used by investors to find great companies at low prices. In this post, we will build a Python script to calculate Price Earnings Ratio for comparable companies. Photo by Skitterphoto on Pexels Price Earnings Ratio and Comparable Compa...
Oct 17, 2023 3:09 PM - Davit Kirakosyan
VMware Stock Drops 12% as China May Hold Up the Broadcom Acquisition
Shares of VMware (NYSE:VMW) witnessed a sharp drop of 12% intra-day today due to rising concerns about China's review of the company's significant sale deal to Broadcom. Consequently, Broadcom's shares also saw a dip of around 4%. Even though there aren’t any apparent problems with the proposed solu...
